Model Check
From $5KTest the model you already have against a private, experimentally measured holdout set.
- Frozen assay and controls
- Predictions locked before testing
- Rank correlation + failure analysis
- Raw data and model-ready CSV
Sequence in · ML-ready experimental data out
Turn protein sequences into biological evidence.
Upload 24–1,000 designs. Get expression, binding, stability and developability measurements back in one model-ready experimental record—including full-length, glycosylated IgG.
START WITH AN EXAMPLE
No account required to start. A Genesis scientist reviews every campaign before scope, timing or pricing becomes a laboratory commitment.
$149Screen bundle
$499full IgG developability
Negative dataincluded by default
Published Genesis launch pricing. Every campaign remains subject to format, target and capacity review.
MODEL DATASET / GBF-024● IN REVIEW
Target areaPD-L1 extracellular domain
Designs48
Panel7 assays
FormatFull IgG
OutputCSV + RAW
01AcceptedSequence & antigen review
02GenerateExpression & purification
03MeasureFixed assay panel
04DeliverAnalysis-ready dataset
01 / Scale & pricing
Start by proving the data changes a decision.
The lowest-friction entry for a foundation-model team is a held-out Model Check: freeze predictions, measure a private cohort, and learn exactly where current performance holds or fails. Scale only after the first dataset earns it.
24–48 held-out designs
Decision Dataset
From $15KGenerate enough comparable data to select candidates, diagnose model errors, or establish a benchmark.
- Multi-property assay panel
- Positive and negative outcomes
- Scientist-designed controls
- Reusable private dataset
Learning Loop
CustomReserve capacity for repeated design–build–test–learn rounds or a proprietary data program.
- Repeated active-learning rounds
- API and campaign workspace
- Reserved laboratory capacity
- Custom methods and rights
THE $5K MODEL CHECK
01
→Submit a model, scoring function or ranked candidate set.
02
→Freeze predictions on a scientist-reviewed holdout cohort.
03
→Receive experimental results, rank metrics and failure analysis.
04
Decide whether a larger dataset can improve the model.
Screen
$149/proteinExpression + binding
~2 weeks
Core
$229/proteinExpression + binding + thermostability
~2 weeks
Developability
$389/proteinSeven co-measured assays
Technical review
Developability — IgG
$499/proteinSeven assays · mammalian · glycosylated
3–5 weeks
250+ −10%500+ −20%1,000+ −25%Open benchmark −20%
Volume and open-data discounts stack. At 1,000 published IgG records, the current launch schedule is approximately $300 per antibody. Prices exclude unusual target sourcing, custom methods and nonstandard material requirements.
THE FULL-LENGTH ADVANTAGE
Do not stop at “does it bind?”
Cell-free screens are excellent for fast small-format validation. Genesis extends the same sequence-to-data experience into the development questions that require mammalian expression, glycosylation and full-length antibody context.
CAPABILITYSMALL-FORMAT SCREENGENESIS FULL IgG
Binding kineticsIncludedIncluded
ThermostabilityIncludedIncluded
SEC + HICAdd Genesis panelIncluded
Polyreactivity + ELISAAdd Genesis panelIncluded
Mammalian glycosylation—Included
Negative outcomesRetainedRetained
02 / Ways to work
Choose one way to get started.
These are three entry points, not sequential steps. Each ends in a defined experimental record: raw files, analyzed values, metadata, QC and labeled failures.
Upload sequences
Choose a published bundle for a defined model-validation or developability cohort.
Plan a data campaign
Describe the target, model objective and decision. We draft the cohort, panel, controls and schema.
Partner with the foundry
Custom assays, repeated active-learning rounds, private datasets and product-development programs.
03 / Campaign workbench
Move from an idea to a technically reviewable request.
This first version prepares the scope. A Genesis scientist confirms feasibility, sample requirements, capacity, timing and final pricing before any SOW is issued.
DATA RIGHTS
Customer project data remains customer-owned by default. Shared benchmarks or reusable dataset rights require a separate opt-in agreement.
CAMPAIGN BRIEF
SCIENTIST REVIEWEDWhat decision should the data support?
04 / Measurement layerOne cohort. One protocol.
One cohort. One protocol.
Every useful outcome retained.
Choose individual assays or a fixed bundle. Method readiness, material requirements and capacity are confirmed during technical acceptance.
COMING SOON
Expression + yield
Standalone expression service. Expression remains scoped within accepted multi-assay campaigns.
$99
Binding kinetics
BLI: KD, kon, koff and sensorgrams
$99
Thermostability
Tm, unfolding curves and replicate QC
$89
SEC aggregation
% monomer, %HMW and chromatograms
$89
HIC hydrophobicity
Relative retention and run-level controls
$109
Polyreactivity
Specificity risk under a frozen method
$79
Functional ELISA
Target-specific functional readout
+$149
Full-length IgG
Mammalian expression and glycosylated context
DELIVERY SCHEMA
Built for analysis, not trapped in a report.
Every campaign includes the experimental context needed to interpret the result and reuse it later.
- Raw instrument files
- Analyzed results
- Replicate-level values
- QC and failure codes
- Construct and run metadata
- Human-readable data dictionary
campaign_results.csv3 / 48 rows shown
| ID | FORMAT | KD nM | % MON | Tm | QC |
|---|---|---|---|---|---|
| GBF-001 | IgG1 | 2.4 | 98.1 | 72.3 | PASS |
| GBF-002 | IgG1 | 8.7 | 95.4 | 68.9 | REVIEW |
| GBF-003 | VHH | 0.9 | 99.2 | 75.1 | PASS |
RAW ATTACHMENTS
sensorgrams/ · chromatograms/ · plate_exports/ · protocol.json · data_dictionary.md
05 / Two buyers, one data engineVolume for models.
Volume for models.
Decisions for pharma.
Foundation-model campaigns build comparable training data and benchmarks. Pharma programs use the same workflow to triage full-length antibody candidates.
Foundation-model teams
- Developability-prediction training sets
- Binder validation with negative data
- Cross-model comparison on one protocol
- Public benchmark contributions
- Antibody-format extension
Pharma biologics teams
- Lead-candidate triage
- Early developability gating
- Biosimilar and comparability screens
- AI-designed candidate validation
- IgG, Fab and scFv format selection
SCIENTIST-REVIEWED SCOPING
Turn one model question into a testable campaign.
Book 25 minutes to review the biological objective, candidate cohort, current model performance, assay panel and the smallest useful pilot. The call produces a next-step recommendation—not an automatic laboratory commitment.
25 minutesGoogle Calendar connectedCal Video
Open booking page ↗06 / Provenance
A new interface, backed by an established diagnostics operation.
20+ yearsDiagnostics R&D and assay development
550,000 ft²Factory area reported by Genesis IVD ↗
ISO systems13485 and 9001 quality discipline
Plate-enabledELISA, BLI, HPLC and FACS
Genesis BioFoundry is a laboratory-data service being developed with Genesis IVD as the initial laboratory and manufacturing partner. Facility, method, quality-system and manufacturing claims refer to Genesis IVD and are confirmed for each accepted program; BioFoundry is not presented as a separately accredited facility.
What data does your model need next?
Bring sequences, a target area or a candidate-ranking problem. We will turn it into a technically reviewable campaign and a reusable experimental record.